Laxmi Dental Ltd
Laxmi Dental Q2 Results 2026 (FY27) investor presentation: Revenue & Margins
Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.
Guidance rank: #10 of 12 in Healthcare Equipment & Supplies
See the sector's top 10 — free with your mobile number.
Laxmi Dental Ltd Q2 FY27 key numbers
- Revenue
- Q2FY27 revenue from operations: INR 795.2 mn, a 10.0% year-on-year (YoY) increase from INR 722.7 mn in Q2FY26.
As stated in Laxmi Dental Ltd's Q2 FY27 investor presentation · published 3 Nov 2026. Reported figures, not investment advice.
Based on Laxmi Dental Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q2FY27 revenue from operations: INR 795.2 mn, a 10.0% year-on-year (YoY) increase from INR 722.7 mn in Q2FY26. Q2 FY27 EBITDA: INR 152.7 mn, a 38.5% year-on-year (YoY) increase from INR 110.2 mn in Q2 FY26.
From Laxmi Dental Ltd's Q2 FY27 earnings-call transcript · updated 3 Nov 2026.
How did Laxmi Dental's revenue grow in the September 2026 quarter?
- Q2FY27 revenue from operations: INR 795.2 mn, a 10.0% year-on-year (YoY) increase from INR 722.7 mn in Q2FY26.
- Dental laboratory business grew 22.7% YoY; international operations up 32.0%, domestic up 15.0%.
- Aligner Solutions revenue up 23.5% YoY, with Bizdent up 27.7% and Vedia up 19.1%.
- Kids-e-Dental paediatric business grew 16.7% YoY.
- Scanner sales declined by 58.8% YoY, affected by high laptop prices.
- H1FY27 revenue: INR 1,542.2 mn, up 11.9% YoY from INR 1,378.6 mn in H1FY26.
- Management states broad-based growth across dental laboratory and aligner segments.
2 more points from Laxmi Dental Ltd's call on revenue
Create a free account to keep reading this call
What happened to Laxmi Dental's margins in Q2 FY27?
See what Laxmi Dental Ltd said on profitability & margins — free account, 30 seconds.
What capex is Laxmi Dental planning?
- ₹128.2 Cr net IPO proceeds, 64% deployed as of 30 Sep 2026.
- Remaining ₹48.1 Cr unutilised IPO proceeds planned for FY27–FY28.
- Deployment includes:
- New machinery at Laxmi: ₹25.7 Cr (₹17.8 Cr utilized of ₹43.5 Cr total).
- New machinery at Bizdent subsidiary: ₹22.4 Cr (₹2.6 Cr used of ₹25.0 Cr total).
- Land & building for new dental lab & aligner manufacturing plant: ₹26.9 Cr (FY27 ₹16.5 Cr, FY28 ₹10.4 Cr).
- Machinery, IT equipment, furniture & fixtures for existing/new facility: ₹21.2 Cr (FY27 ₹13.9 Cr, FY28 ₹7.3 Cr).
- Rationale: owned plant and aligner manufacturing to scale capacity; reduce costs (rent, electricity); improve operational efficiency and technology adoption via single-floor setup.
2 more points from Laxmi Dental Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Equipment & Supplies
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is Laxmi Dental raising money or cutting debt?
See what Laxmi Dental Ltd said on fundraising & capital structure — free account, 30 seconds.
How big is Laxmi Dental's order book?
See what Laxmi Dental Ltd said on order book & pipeline — free account, 30 seconds.
Laxmi Dental Ltd — Quarterly revenue & net profit
Q2 FY27 figures are not in this chart yet. Latest shown: Jun 2026 (Q1 FY27). The Q2 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q1 FY27): revenue ₹75 Cr, net profit ₹10 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Laxmi Dental's management said in earlier quarters
Others in Healthcare Equipment & Supplies this season
- Galaxy Medicare (Q2 FY27)
Revenue from Operations (₹ Mn): . Key investor presentation takeaways from Galaxy Medicare's Q2 FY27 investor presentation — and how it ranks against sector pee
- Nureca Ltd (Q2 FY27)
Year-on-year growth in revenue from operations: approximately 55% increase (585.99 vs 378.41 million standalone) . Key results statement takeaways from Nureca's
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Equipment & Supplies
on management's own guidance
- Strong growth2
- Strong growth1
- Molbio DiagnostiGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Laxmi Dental Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Laxmi Dental Ltd Q2 FY27 results?
Q2FY27 revenue from operations: INR 795.2 mn, a 10.0% year-on-year (YoY) increase from INR 722.7 mn in Q2FY26. Q2 FY27 EBITDA: INR 152.7 mn, a 38.5% year-on-year (YoY) increase from INR 110.2 mn in Q2 FY26.
What is Laxmi Dental Ltd share price analysis?
Laxmi Dental Ltd currently shows a neutral. The stock trades at a P/E of 28.7 with a market cap of ₹999 Cr. Investors should review the full earnings analysis for detailed insights.
Is Laxmi Dental Ltd planning capital expenditure?
₹128.2 Cr net IPO proceeds, 64% deployed as of 30 Sep 2026.
Keep Laxmi Dental Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.